| Product NDC: | 0004-0086 | 
| Proprietary Name: | Copegus | 
| Non Proprietary Name: | Ribavirin | 
| Active Ingredient(s): | 200 mg/1 & nbsp; Ribavirin | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0086 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021511 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20021203 | 
| Package NDC: | 0004-0086-94 | 
| Package Description: | 168 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0086-94) | 
| NDC Code | 0004-0086-94 | 
| Proprietary Name | Copegus | 
| Package Description | 168 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0086-94) | 
| Product NDC | 0004-0086 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Ribavirin | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20021203 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | RIBAVIRIN | 
| Strength Number | 200 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |